Evolution and epidemiology of extended-spectrum beta-lactamases (ESBLs) and ESBL-producing microorganisms
- PMID: 11737084
- DOI: 10.1046/j.1198-743x.2001.00330.x
Evolution and epidemiology of extended-spectrum beta-lactamases (ESBLs) and ESBL-producing microorganisms
Abstract
The rapid and irrepressible increase in antimicrobial resistance of pathogenic bacteria that has been observed over the last two decades is widely accepted to be one of the major problems of human medicine today. Several aspects of this situation are especially worrying. There are resistance mechanisms that eliminate the use of last-choice antibiotics in the treatment of various kinds of infection. Many resistance mechanisms that emerge and spread in bacterial populations are those of wide activity spectra, which compromise all or a majority of drugs belonging to a given therapeutic group. Some mechanisms of great clinical importance require specific detection procedures, as they may not confer clear resistance in vitro on the basis of the interpretive criteria used in standard susceptibility testing. Finally, multiple mechanisms affecting the same and/or different groups of antimicrobials coexist and are even co-selected in more and more strains of pathogenic bacteria. The variety of beta-lactamases with wide spectra of substrate specificity illustrates very well all the phenomena mentioned above. Being able to hydrolyze the majority of beta-lactams that are currently in use, together they constitute the most important resistance mechanism of Gram-negative rods. Three major groups of these enzymes are usually distinguished, class C cephalosporinases (AmpC), extended-spectrum beta-lactamases (ESBLs) and different types of beta-lactamases with carbapenemase activity, of which the so-called class B metallo-beta-lactamases (MBLs) are of the greatest concern. This review is focused on various aspects of the evolution and epidemiology of ESBLs; it does not cover the problems of ESBL detection and clinical relevance of infections caused by ESBL-producing organisms.
Similar articles
-
Epidemiology of β-Lactamase-Producing Pathogens.Clin Microbiol Rev. 2020 Feb 26;33(2):e00047-19. doi: 10.1128/CMR.00047-19. Print 2020 Mar 18. Clin Microbiol Rev. 2020. PMID: 32102899 Free PMC article. Review.
-
[Appearance of extended-spectrum beta-lactamases].Nihon Rinsho. 1997 May;55(5):1219-24. Nihon Rinsho. 1997. PMID: 9155178 Review. Japanese.
-
Extended Spectrum Beta-lactamases: Definition, Classification and Epidemiology.Curr Issues Mol Biol. 2015;17:11-21. Epub 2014 May 12. Curr Issues Mol Biol. 2015. PMID: 24821872 Review.
-
Molecular epidemiology of extended-spectrum β-lactamase-, AmpC β-lactamase- and carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolated from Canadian hospitals over a 5 year period: CANWARD 2007-11.J Antimicrob Chemother. 2013 May;68 Suppl 1:i57-65. doi: 10.1093/jac/dkt027. J Antimicrob Chemother. 2013. PMID: 23587779
-
Characteristics, epidemiology and clinical importance of emerging strains of Gram-negative bacilli producing extended-spectrum beta-lactamases.Res Microbiol. 2004 Jul-Aug;155(6):409-21. doi: 10.1016/j.resmic.2004.02.009. Res Microbiol. 2004. PMID: 15249058 Review.
Cited by
-
Antimicrobial resistance and prevalence of extended-spectrum beta-lactamase-producing Klebsiella species in East Tennessee dairy farms.Microbiol Spectr. 2024 Oct 3;12(10):e0353723. doi: 10.1128/spectrum.03537-23. Epub 2024 Sep 6. Microbiol Spectr. 2024. PMID: 39240080 Free PMC article.
-
Multi-drug resistant (MDR) Gram-negative pathogenic bacteria isolated from poultry in the Noakhali region of Bangladesh.PLoS One. 2024 Aug 1;19(8):e0292638. doi: 10.1371/journal.pone.0292638. eCollection 2024. PLoS One. 2024. PMID: 39088478 Free PMC article.
-
Extended Spectrum beta-Lactamase Bacteria and Multidrug Resistance in Jordan are Predicted Using a New Machine-Learning system.Infect Drug Resist. 2024 Jul 25;17:3225-3240. doi: 10.2147/IDR.S469877. eCollection 2024. Infect Drug Resist. 2024. PMID: 39081458 Free PMC article.
-
New Agents Are Coming, and So Is the Resistance.Antibiotics (Basel). 2024 Jul 13;13(7):648. doi: 10.3390/antibiotics13070648. Antibiotics (Basel). 2024. PMID: 39061330 Free PMC article. Review.
-
Characterization of Extended-Spectrum β-Lactamase-Producing Escherichia coli in Animal Farms in Hunan Province, China.Microorganisms. 2024 Mar 26;12(4):653. doi: 10.3390/microorganisms12040653. Microorganisms. 2024. PMID: 38674598 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical